INCREASED PLASMA PHOSPHATIDYLCHOLINE/LYSOPHOSPHATIDYLCHOLINE RATIOS IN PATIENTS WITH PARKINSON'S DISEASE.
Changes of the lipid composition might be associated with the onset and progression of various neurodegenerative diseases. Herein, we investigated the changes in the plasma phosphatidylcholine (PC)/lysophosphatidylcholine (LPC) ratios in patients with Parkinson's disease (PD) in comparison to healthy subjects and their correlation with clinico-pathological features. The study included 10 controls and 25 patients with PD. All patients were assigned into groups based on clinico-pathological characteristics (gender, age at examination, duration of the disease, and the Hoehn and Yahr (H&Y) stage). The analysis of the PC/LPC intensity ratios in plasma lipid extracts was performed by using matrix-assisted laser desorption and ionization time-of-flight mass spectrometry (MALDI-TOF MS). PD patients exhibited an increased PC/LPC intensity ratio in comparison to the control group of healthy subjects. Furthermore, the investigated ratio has shown to be correlated with clinico-pathological parameters, in particular with the H&Y stage and disease duration. The PC/LPC intensity ratio in plasma samples of PD patients was found to be elevated in all examined H&Y stages and throughout the disease duration. To our knowledge, this is the first study examining the PC/LPC ratio in plasma of patients with PD and illustrating its correlation with clinico-pathological features. Although the presented results may be considered as preliminary due to the limited number of participants, the observed alterations of PC/LPC ratio in plasma might be a first step in the characterization of plasma lipid changes in PD patients and an indicator of lipids reconfiguration.